Patent · US Active

Cancer cell detection method using living body-derived cells

US10551387B2 · kind B2 · utility

1Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2015
Grant dateFeb 4, 2020
Priority date
Expiry dateApr 12, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/48
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A cancer cell detection method that makes it possible to perform imaging of cells in a living state and a dual detection method for cancer cells in which the aforementioned method is combined with a pre-existing dyeing method for cytodiagnosis. The method uses living body-derived cells and includes: incubating living cells included in a sample taken from a person together with a fluorescently-labeled L-glucose derivative and detecting the fluorescently-labeled L-glucose derivative that is taken up into the cells; and detecting fluorescence emitted by the L-glucose derivative that is present within the cells while the cells are attached to a thin glass or plastic plate. Also provided is a dual detection method for cancer cells in which the cancer cell detection method that uses living body-derived cells is combined with a dyeing method using cells that are fixed using an alcohol or the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.